Is Insmed Incorporated (INSM) a Promising Biotech Stock According to Wall Street Analysts [Yahoo! Finance]
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference [Yahoo! Finance]
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Bank of America Co. from $92.00 to $96.00. They now have a "buy" rating on the stock.
Insmed Incorporated (NASDAQ: INSM) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $100.00 price target on the stock.